Disciplined Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7
Closed -$900 512
2023
Q2
$900 Sell
7
-2
-22% -$242 ﹤0.01% 1016
2023
Q1
$1.05K Hold
9
﹤0.01% 930
2022
Q4
$1.02K Buy
9
+1
+13% +$110 ﹤0.01% 898
2022
Q3
$1K Buy
8
+1
+14% +$85 ﹤0.01% 865
2022
Q2
$1K Sell
7
-9
-56% -$821 ﹤0.01% 880
2022
Q1
$2K Buy
+16
New +$1.75K ﹤0.01% 671
2020
Q1
Sell
-20
Closed -$1K 431
2019
Q4
$1K Buy
+20
New +$949 ﹤0.01% 400

Other funds holding DXCM

Disciplined Investments's DXCM Position: Q3 2023 in Review

Disciplined Investments sold out of DexCom (DXCM) in Q3 2023, closing a stake of 7 shares — an estimated $900 sold.

Disciplined Investments first reported a position in DXCM in Q4 2019 and held it in 7 quarters. The position peaked at $2K in Q1 2022. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Disciplined Investments reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 7 DexCom shares in Q3 2023, an estimated $900.
  • Disciplined Investments first reported a position in DexCom in Q4 2019 and held it in 7 quarters.
  • Disciplined Investments's DexCom position peaked at $2K in Q1 2022.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.